image
Inhibikase Therapeutics, Inc. IKT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.05
-13.1 %
$ 138 M
Market Cap
-0.64
P/E
CASH FLOW STATEMENT
-18.1 M OPERATING CASH FLOW
-4.23%
Growth Rates
1Year -4.23%
3Years -152.06%
5Years -92.30%
7Years -150.07%
10Years 0.00%
11.7 M INVESTING CASH FLOW
172.83%
Growth Rates
1Year 172.83%
3Years 0.00%
5Years 166.27%
7Years 0.00%
10Years 0.00%
8.41 M FINANCING CASH FLOW
4204.63%
Growth Rates
1Year 4204.63%
3Years -17.68%
5Years 84.08%
7Years 131.43%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Inhibikase Therapeutics, Inc.
image
Net Income -19 M
Depreciation & Amortization 177 K
Capital Expenditures -14.2 K
Stock-Based Compensation 500 K
Change in Working Capital 235 K
Others 731 K
Free Cash Flow -18.1 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (19.0) (18.1) (14.8) (2.8) (5.7) (2.2) (0.4) (0.6)
Depreciation & Amortization 0.2 6.72 K 0 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0 0 0 0
Stock Based Compensation 0.5 0.5 1.5 0.6 1.4 0.6 0.3 0.3
Other Operating Activities 31.5 K 67 K 0.7 1.6 2.3 0.7 0.5 95.7 K
Change in Working Capital 0.2 0.2 (1.8) (0.5) 1.6 1.5 32.8 K 0.2
Cash From Operations (18.1) (17.4) (14.3) (1.1) (0.3) 0.7 (0.1) 29.6 K
INVESTING CASH FLOW
Capital Expenditures 14.2 K (0.2) 0 0 0 0 0 0
Other Items 11.7 (15.8) 0 0 0 87.1 K 0 0
Cash From Investing Activities 11.7 (16.0) 0 0 0 87.1 K 0 0
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 0 (0.2) 42.5 K 0.3 22.8 K 26.3 K 0 0
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities (0.1) 0 848 0 0 (1.6) 0.1 23.8 K
Cash From Financing Activities 8.4 (0.2) 41.1 15.1 22.8 K (0.4) 0.1 23.8 K
CHANGE IN CASH
Net Change In Cash 2.0 (33.6) 26.8 13.9 (0.4) 0.4 4.63 K 53.3 K
FREE CASH FLOW
Free Cash Flow (18.1) (17.6) (14.3) (1.1) (0.3) 0.7 (0.1) 29.6 K